Indian SLE Inception cohort for Research (INSPIRE): the design of a multi-institutional cohort

• Published in: Rheumatology international Vol. 41; no. 5; pp. 887 - 894
• Main Authors: Shobha, Vineeta, Aggarwal, Amita, Rajasekhar, Liza, Jain, Avinash, Gupta, Ranjan, Das, Bidyut, Mathew, Ashish J., Rathi, Manish, Ghosh, Parasar, Negi, Vir Singh, Tripathi, Abhishek, Misra, Ramnath
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-05-2021; Springer Nature B.V
• Subjects: Cohort Studies; Ethnicity; Lupus; Medicine; Medicine & Public Health; Rheumatology; India; Inception cohort; Systemic lupus erythematosus; Outcomes; Lupus registry; India
• ISSN: 0172-8172; 1437-160X
• DOI: 10.1007/s00296-020-04766-3

Systemic lupus erythematosus (SLE) cohorts across the world have allowed better understanding of SLE, including its bimodal mortality, and the impact of social factors and ethnicity on outcomes. The representation of patients from South Asia has been poor in the existing SLE cohorts across the world. Hence, we planned to initiate an inception cohort to understand the diversity of lupus in India. Indian SLE Inception cohort for REsearch (INSPIRE), planned over 5 years is a multi-centric cohort of adult and childhood lupus patients of Indian origin, fulfilling the SLICC-2012 classification criteria, with an aim to provide cross-sectional information on demography, ethnicity, socio-economic status, standard disease variables, quality of life, and prospective information on new events like hospitalization, infections, pregnancies, changes in disease activity, and damage. One of the other deliverables of this project is the establishment of a biorepository. The instruments to be used for each variable and outcome were finalized, and a web-enabled case report form was prepared to encompass SLEDAI, BILAG, SLICC damage scores, and Lupus quality-of-life index.
Ten centers located in different geographic areas of India would enroll patients who are seen for the first time after the start of the study. In the first 8 months, 476 patients (63 children, 36 males) have been enrolled with a median disease duration of 10 (IQR 4–17) months and mucocutaneous features being the most prevalent clinical manifestations. INSPIRE is the first prospective Indian SLE cohort to study the diversity of Indian patients.